Marburg Virus

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".

Deadline for manuscript submissions: 31 October 2025 | Viewed by 213

Special Issue Editors


E-Mail Website
Guest Editor
1. School of Health Systems & Public Health, University of Pretoria, Pretoria 0002, South Africa
2. ICAP, Columbia University, New York, NY, USA
Interests: COVID-19; public health response; public health policy; health systems
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda
2. Rwanda Biomedical Centre, Kigali, Rwanda
Interests: infectious diseases; clinical microbiology; tuberculosis; hepatitis

Special Issue Information

Dear Colleagues,

Marburg virus disease (MVD) remains one of the most concerning viral hemorrhagic fevers due to its high mortality rate and limited treatment options. Caused by the Marburg virus (MARV), a member of the Filoviridae family, this disease poses a significant threat to public health, particularly in regions experiencing zoonotic spillover events and outbreaks. MARV infection is characterized by severe clinical presentations, necessitating an in-depth understanding of the virus’s epidemiology, pathogen-host interactions, immune responses, mechanisms of immune evasion, and current insights on vaccine and therapeutics development. This Special Issue on "Marburg Virus" aims to provide a comprehensive platform for current research and insights into all aspects of Marburg virus disease, from epidemiological patterns to advancements in vaccines and therapeutic interventions. Contributions that enhance our understanding of MARV immune responses, host defense mechanisms, and the public health impact are particularly encouraged. We welcome the submission of high-quality original research articles, reviews, and commentaries that address a broad range of topics, including but not limited to epidemiology, pathogen-host interactions, immune response and defense mechanisms, vaccine and therapeutic development, treatment, and public health implications. This issue is intended to serve as a comprehensive resource for researchers, healthcare professionals, and policymakers. We encourage submissions from diverse scientific disciplines, including virology, immunology, epidemiology, and public health.

Dr. Tafadzwa Dzinamarira
Prof. Dr. Claude Mambo Muvunyi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Marburg virus
  • viral hemorrhagic fever
  • epidemiology
  • pathogen-host interaction
  • immune response
  • vaccine development
  • public health

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop